Literature DB >> 23594152

Tumour diameter is a predictor of mesorectal and mesenteric lymph node metastases in anorectal melanoma.

M Wang1, Z Zhang, J Zhu, W Sheng, P Lian, F Liu, S Cai, Y Xu.   

Abstract

AIM: Anorectal melanoma is a rare neoplasm with poor prognosis. The aim of this study was to investigate what clinicopathological factors predict lymph node metastases and to investigate their association with survival.
METHOD: Patients undergoing surgery with curative intent for primary anorectal melanoma in Fudan University Shanghai Cancer Center between 1989 and 2011 were studied retrospectively. The associations between clinicopathological factors and lymph node metastases and prognosis were determined.
RESULTS: Forty-three patients underwent a potentially curative resection with a median follow-up of 20 months; the 5-year overall survival rate was 29.6% with median overall survival of 28 months. Tumour diameter > 3 cm was associated with mesorectal and mesenteric lymph node metastases (P = 0.013). Perineural invasion (hazard ratio 5.683; 95% CI 1.978-16.328; P = 0.001) was the only factor that independently predicted survival.
CONCLUSION: Tumour diameter was associated with mesorectal and mesenteric lymph node metastases; therefore, wide local excision may not be appropriate for surgery with curative intent for patients with a tumour diameter ≥ 3 cm. Perineural invasion was an important prognostic factor for anorectal melanoma. Colorectal Disease
© 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Anorectal melanoma; lymph node metastases; prognosis; surgery

Mesh:

Year:  2013        PMID: 23594152     DOI: 10.1111/codi.12250

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  8 in total

Review 1.  [Anorectal malignant melanoma : Treatment recommendations].

Authors:  T R Glowka; M D Keyver-Paik; T Thiesler; J Landsberg; J C Kalff; D Pantelis
Journal:  Chirurg       Date:  2016-09       Impact factor: 0.955

2.  Primary anorectal malignant melanoma with laparoscopic abdominoperineal resection: a case study and review of the relevant literature.

Authors:  Kentaro Nonaka; Kensuke Kudou; Shun Sasaki; Tomoko Jogo; Kosuke Hirose; Yuta Kasagi; Qingjiang Hu; Yasuo Tsuda; Yuichi Hisamatsu; Koji Ando; Yuichiro Nakashima; Hiroshi Saeki; Eiji Oki; Mitsuo Kamori; Masaki Mori
Journal:  Int Cancer Conf J       Date:  2020-04-17

Review 3.  Beyond adenocarcinoma: MRI of uncommon rectal neoplasms and mimickers.

Authors:  David D B Bates; Maria Clara Fernandes de Paula; Natally Horvat; Shannon Sheedy; Chandana Lall; Zahra Kassam; Perry Pickhardt; Neeraj Lalwani; Dhakshinamoorthy Ganeshan; Iva Petkovska
Journal:  Abdom Radiol (NY)       Date:  2019-11

4.  Primary anorectal malignant melanomas: retrospective analysis of 11 cases in a single center.

Authors:  Erol Pişkin; Osman Aydın; Abdullah Şenlikçi; Mehmet Yiğit Özgün; Volkan Öter; Erdal Birol Bostancı
Journal:  Turk J Surg       Date:  2021-03-22

5.  Primary anorectal melanoma-a rare entity: case report.

Authors:  Konstantinos Kothonidis; Fadi Maassarani; Yves Couvreur; Bernard Vanhoute; Robert De Keuleneer
Journal:  J Surg Case Rep       Date:  2017-03-29

6.  Computer-assisted measurement of primary tumor area is prognostic of recurrence-free survival in stage IB melanoma patients.

Authors:  Brooke E Rosenbaum; Christine N Schafer; Sung Won Han; Iman Osman; Hua Zhong; Nooshin Brinster
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

7.  Anorectal malignant melanoma: curative abdominoperineal resection: patient selection with 18F-FDG-PET/CT.

Authors:  Claudius Falch; Sven Mueller; Andreas Kirschniak; Manuel Braun; Alfred Koenigsrainer; Bernhard Klumpp
Journal:  World J Surg Oncol       Date:  2016-07-15       Impact factor: 2.754

8.  Surgical treatment of anorectal melanoma: a systematic review and meta-analysis.

Authors:  Esther Jutten; Schelto Kruijff; Anne Brecht Francken; Martijn F Lutke Holzik; Barbara L van Leeuwen; Henderik L van Westreenen; Kevin P Wevers
Journal:  BJS Open       Date:  2021-11-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.